Alessio Bruscaggin

3PUBLICATIONS
61CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 14, 2025
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Alberto J Arribas, Francesca Guidetti, Eleonora Cannas

|May 13, 2025
A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA.

Maria Cristina Pirosa, Alessio Bruscaggin, Lodovico Terzi di Bergamo

|Jan 18, 2025
Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels.

Riccardo Moia, Donatella Talotta, Lodovico Terzi Di Bergamo

Pageof 1